Le Lézard
Classified in: Health
Subjects: POL, CFG

MHCC mobilizes to prevent suicide


From Mental Health Commission of Canada

OTTAWA, Sept. 10, 2018 /CNW/ - Today, on World Suicide Prevention Day, we are reminded that everyone can make a contribution to suicide prevention. The Mental Health Commission of Canada (MHCC) is taking concrete steps to help individuals and communities across Canada prevent suicide by building resources and tools, and mobilizing the uptake of best practices. Our work includes:

Every year in Canada, an estimated 4,000 people take their lives. Suicide affects all ages and people from all walks of life.

Under the theme Working Together to Prevent Suicide, the MHCC joins other partners to ask everyone to come together and remind each other that help, hope and healing are possible. As a national leader in mental health resource and policy development, the MHCC is fulfilling its commitment to meet the needs of people affected by suicide.

On World Suicide Prevention Day, I invite everyone to take action by sharing resources like our toolkits for people affected by suicide and by posting a positive message on social media through our #sharehope wall.

If you or someone you care about needs immediate help, reach out to the local crisis line in your region.

Together we can stop suicide.

Louise Bradley
President and CEO, Mental Health Commission of Canada

Stay Connected

Follow MHCC on Facebook

Follow MHCC on Twitter

Follow MHCC on LinkedIn

Follow MHCC on Instagram

Subscribe to MHCC on YouTube

 

SOURCE Mental Health Commission of Canada


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: